Bioniche Life Sciences (T.BNC) hit a new 52-week high of $1.14; Bioniche Life Sciences Inc. announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals (Nasdaq: ENDP) for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America. The achievement of these milestones triggers a total payment of $8 million U.S. to Bioniche from Endo.
Endo Pharmaceuticals has also elected to exercise its option for exclusive rights to develop and market the product globally. As a result of the decision, Endo will all assume all external development expenses for the product.
BNK Petroleum Inc. (T.BKX) hit a new 52-week high of $2.33; no news announcements today
Richelieu Hardware (T.RCH) hit a new 52-week high of $23.50 no news announcements today
BPO Properties Ltd (T.BPP) hit a new 52-week high of $20.67 no news announcements today
Delphi Energy Corp. (T.DEE) hit a new 52-week high of $2.40; no news announcements today
Vero Energy Inc. (T.VRO) hit a new 52-week high of $7.40; no news announcements today
Total Energy Services Inc. (T.TOT) hit a new 52-week high of $8.64; no news announcements today
Tethys Petroleum Ltd. (T.TPL) hit a new 52-week high of $2.04; no news announcements today
Related Stories
